Apple stock price today: AAPL edges up as China discounts and Siri chatbot plans hit the tape
22 January 2026
1 min read

Apple stock price today: AAPL edges up as China discounts and Siri chatbot plans hit the tape

NEW YORK, Jan 22, 2026, 09:34 EST — Regular session

Apple shares edged up 0.4% to $247.65 in early Thursday trading, as the spotlight stayed on the iPhone maker following new developments from China and efforts to revamp Siri.

Apple faces a pivotal week as it prepares to release first-quarter earnings on Jan. 29. Investors are eager for clear insights on holiday sales and any changes to margin forecasts or the services segment. 1

In this environment, even minor signals carry weight. A price shift in China could signal changing demand, while the Siri developments show how fast Apple might catch up on consumer AI without disrupting its iPhone business.

Apple announced on its website that it will slash prices by as much as 1,000 yuan ($143.60) on certain iPhone, Mac, iPad, and Apple Watch models in China from Jan. 24 to Jan. 27. The new iPhone 17 is not part of the promotion. 2

Another piece fed the AI buzz surrounding the stock. Bloomberg News reported that Apple intends to overhaul Siri this year, transforming it into the company’s first AI chatbot, integrated more extensively across iPhone, iPad, and Mac platforms. Apple declined to comment when Reuters reached out. 3

Regulatory scrutiny is on the rise again. Apple has petitioned a Delhi High Court judge to block the Competition Commission of India from accessing its global financial records amid an app store investigation, court documents reveal. The company is also contesting India’s penalty framework. The case is set for a hearing on Jan. 27. 4

Costs remain a key issue heading into earnings. A Reuters report on soaring memory chip prices pointed to Apple’s advantage over smaller competitors, thanks to its reliance on contract pricing—long-term agreements that help lock in costs—versus the unpredictable spot market. Still, analysts warn Apple might need to hike prices eventually. “Apple is better-positioned,” said Morningstar’s William Kerwin, “but it isn’t immune.” 5

Apple’s subdued shift unfolded as market sentiment firmed. Wall Street’s key indexes looked poised to push higher after President Donald Trump eased tariff threats against Europe. Investors kept an eye on the personal consumption expenditures price index, the Fed’s preferred inflation measure, scheduled for release at 10 a.m. ET. 6

Still, the straightforward story remains out of reach. Discounts in China might boost unit sales without improving profit per device. Meanwhile, a bigger-than-anticipated rise in component costs could trigger tough choices between margin and pricing — particularly if demand weakens.

Traders face a packed schedule: Apple kicks off its China promotion on Jan. 24, the India court hearing follows on Jan. 27, and Apple’s earnings drop Jan. 29. U.S. inflation numbers are also expected later Thursday.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Amazon stock wobbles after Jassy flags tariff “creep” into prices — what AMZN traders watch next
Previous Story

Amazon stock wobbles after Jassy flags tariff “creep” into prices — what AMZN traders watch next

60 Degrees Pharmaceuticals (SXTP) stock more than triples as Runway Health deal hits tape
Next Story

60 Degrees Pharmaceuticals (SXTP) stock more than triples as Runway Health deal hits tape

Go toTop